CN104341359B - Preparation method of tetramethyl-pyrazine - Google Patents

Preparation method of tetramethyl-pyrazine Download PDF

Info

Publication number
CN104341359B
CN104341359B CN201410630743.7A CN201410630743A CN104341359B CN 104341359 B CN104341359 B CN 104341359B CN 201410630743 A CN201410630743 A CN 201410630743A CN 104341359 B CN104341359 B CN 104341359B
Authority
CN
China
Prior art keywords
ammonium formate
tetramethylpyazine
pyrazine
tetramethyl
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410630743.7A
Other languages
Chinese (zh)
Other versions
CN104341359A (en
Inventor
皮金红
董建强
丁友友
赵涛涛
郭东坡
魏金维
张琦
谢国范
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUHAN WUYAO PHARMACEUTICAL CO Ltd
Original Assignee
WUHAN WUYAO PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUHAN WUYAO PHARMACEUTICAL CO Ltd filed Critical WUHAN WUYAO PHARMACEUTICAL CO Ltd
Priority to CN201410630743.7A priority Critical patent/CN104341359B/en
Publication of CN104341359A publication Critical patent/CN104341359A/en
Application granted granted Critical
Publication of CN104341359B publication Critical patent/CN104341359B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to a synthesis method of medical intermediate tetramethyl-pyrazine. The method takes butanedione monoxime as raw material, water as a solvent and palladium carbon as a catalyst, and comprises the steps of feeding ammonium formate in a reflux state, continuously carrying out reflux mixing for 4 hours after the ammonium formate is fed, filtering to remove the catalyst, cooling, extracting dichloromethane, and concentrating under the reduced pressure to obtain the tetramethyl-pyrazine. The method for preparing the tetramethyl-pyrazine is mild in reaction conditions and simple and convenient in aftertreatment, has the conversion rate of more than 95% and the yield of more than 80%, and is lower in cost and beneficial to industrial production.

Description

A kind of preparation method of tetramethylpyazine
Technical field
The present invention relates to medicinal chemistry art, be specifically related to the system of a kind of medicine intermediate tetramethylpyazine Preparation Method.
Background technology
Tetramethylpyazine, chemical formula is: C8H14N2, colorless needle crystals, molecular weight 136.20 melts Point: 82~84 DEG C, boiling point: 190 DEG C.Its structural formula is:
This material has aromatic odor, hygroscopicity, easily distils.It is soluble in hot water, petroleum ether, chloroform, micro- It is dissolved in ether, insoluble in cold water.
Tetramethylpyazine can serve as flavoring agent, spice, food flavor agent, medicine and the centre of pesticide Body.People find that again tetramethylpyazine is chuanxiong (Ligusticum chuanxiong in recent years Hort) one of effective ingredient, clinically primary treatment ischemic cardio cerebrovascular diseases.Particularly Pharmaceutically, there is blood pressure lowering, expand blood vessel thrombolytic effect, be mainly used in clinically treating ischemic cardiac Cerebrovascular disease, such as cardio cerebrovascular affection, cerebral embolism, coronary heart disease, angina pectoris, vasculitis, chronic Pulmonary heart disease, chronic renal failure etc..Discovered in recent years has calcium ion retardation, has chemotherapy to increase Quick reversing multiple medicine resistance of tumor cells effect.
Patent CN1274722A, with zinc powder reduction, prepares tetramethyl in ammonium chloride, water and acetic acid solution Base pyrazine (" Chinese herbal medicine " 1980,11 (3): 198).Yield about 35%, its reaction equation is:
This route consumes a large amount of glacial acetic acid and zinc powder, and discharge garbage is more, relatively costly, is unfavorable for industry Metaplasia is produced.
Patent CN1935794A, with 3-hydroxy-2-butanone and ammonium acetate as raw material, with ethanol as solvent, It is passed through nitrogen, heating bath stirring 5-8h, uncovered stirring 12h, reoxidizes agent manganese dioxide stirring 2h, subtract Pressure distillation obtains tetramethylpyazine, yield 72% twice.This reaction time is longer, and post processing is loaded down with trivial details.
Synthesis,(8),701-2;1990. with acetonitrile as raw material, and oxolane is solvent, in four chlorinations Titanium and the catalysis of zinc powder, return stirring 4-6d under inert gas shielding, concentrate cooling adds potassium carbonate Tetramethylpyazine, yield 44% is obtained with chloroform extraction after solution.The method reaction equation is:
This synthetic method response time is longer, and yield is the highest, is not suitable for industrialized production.
Patent U.S.6225471B1, with 3-hydroxy-2-butanone as raw material, adds acetic acid with water for solvent Ammonium, sodium acetate and hydrogen peroxide, use decompression condensation equipment, reaction to terminate to collect distillation condensed product, Residual liquid adds 10%NaOH and adjusts filtration after PH, and hot water recrystallization, total recovery is up to 90%.
The method is easy, and yield is high, but needs special decompression condensation equipment.
By the side of the coordination catalysis synthesis tetramethylpyazine that VIII race's metallic compound and organic ligand are formed Method has: patent CN1253134A is with CoCl2PdCl2For under catalysts conditions, hydrogenation pressure is 4Mpa, temperature 120 DEG C reduction conversion ratio is up to 96.52%, and yield is 94.44%.Zhejiang University Wang Xiangyu, with ethanol as solvent, hydrogenates under palladium-triphenyl phosphine catalyst 1.2MPa pressure at a temperature of 150 DEG C Maximum conversion rate reaches 94.69%, yield 91.81%.Article J.Am.Chem.Soc.55,4167 (1933) Report under the conditions of Raney Raney nickel, with the Hydrogen Vapor Pressure of 10~20Mp, with diacetyl list Oxime is that tetramethylpyazine is prepared in raw material reduction.
Although three kinds of catalytic hydrogenation yields are higher, but all use high-temperature high-voltage reaction condition, from resistance to , there is certain security risk in pressure consersion unit and security consideration.
Summary of the invention
It is an object of the invention to find one under relatively mild reaction condition, be not related to corrosivity and be situated between Matter, is prepared tetramethylpyazine by biacetyl monoxime, ammonium formate through palladium charcoal catalytic hydrogen transfer, it is thus achieved that higher The synthetic method of the tetramethylpyazine of yield.
Realization the technical scheme is that
With biacetyl monoxime as raw material, adding water and make catalyst as solvent, palladium charcoal, its mol ratio is palladium Charcoal: biacetyl monoxime=0.0005~0.1:1 are dividedly in some parts ammonium formate at reflux, its mol ratio is: 5~11:1, reflux temperature is 90~95 DEG C, after ammonium formate adds, and continuation return stirring 2~4 hours, Filtration of catalyst, dichloromethane extraction after cooling, concentrating under reduced pressure obtains tetramethylpyazine.Reduce pressure dense Contracting condition be pressure be 0.9~1.0Mp, temperature is 20~35 DEG C.
The process of preparation reaction is:
Present invention have the advantage that
(1) raw material reaction in preparation process of the present invention is complete, and in discharge, organic substance residues amount is few, It is beneficial to environmental protection.
(2) present invention relatively other synthetic route tetramethylpyazine productivity are high.
(3) present invention uses palladium charcoal to be catalyzed, and is not required to high-pressure hydrogenation, and reaction condition is gentle, meets green Color chemical industry theory, simple to operate, it is more suitable for industrialization.
Detailed description of the invention
It is embodied as step below by what some embodiments described the present invention in detail, should be real by these Execute the example restriction as the scope of the invention.
Embodiment 1
By 10.0g biacetyl monoxime, 10.0g palladium carbon adds to 120ml methanol, then stirs intensification To 60 DEG C.Add 67.4g ammonium formate in batches, after ammonium formate adds, in 60~65 DEG C of return stirrings 2 hours.After reaction terminates, cloth is filtered to remove palladium carbon (recovery), and after adding hydrochloric acid, decompression removes Solvent methanol, adds 120mL water, and NaOH regulates pH 8~9, extracts three by 60ml ethyl acetate Secondary, merge organic facies, add anhydrous sodium sulfate and be dried, filter, concentrating under reduced pressure obtains tetramethylpyazine 5.3g, Yield is 79.2%.
Embodiment 2
By 10.0g biacetyl monoxime, 5.0g palladium carbon adds to 120ml water, and then stirring is warming up to 90℃.Add 50.5g ammonium formate in batches, after ammonium formate adds, in 95~100 DEG C of return stirrings 2 Hour.After reaction terminates, removing palladium carbon, filtrate is with dichloromethane (CH2Cl2) extract three times, close And organic facies, adding anhydrous sodium sulfate and be dried, filter, concentrating under reduced pressure obtains tetramethylpyazine 5.6g, receives Rate is 83.7%.
Embodiment 3
By 10.0g biacetyl monoxime, 1.0g palladium carbon adds to 134ml water, and then stirring is warming up to 80~90 DEG C.Add 67.4g ammonium formate (HCOONH4) in batches, after ammonium formate adds, continue Return stirring 4 hours.After reaction completely, removing palladium carbon with buchner funnel decompression sucking filtration, filtrate is with two Chloromethanes (CH2Cl2) extracts three times, merges organic facies, adds anhydrous sodium sulfate and is dried, filters, Concentrating under reduced pressure obtains tetramethylpyazine 5.7g, and yield is 84.6%.

Claims (2)

1. the preparation method of a medicine intermediate tetramethylpyazine, the method comprises the steps: with biacetyl monoxime as raw material, water as solvent, palladium charcoal makees catalyst, adding ammonium formate, be stirred at reflux reaction after adding, reaction terminates rear Filtration of catalyst, solvent extraction after cooling, concentrating under reduced pressure obtains tetramethylpyazine;Palladium charcoal with the mol ratio of biacetyl monoxime is: 0.0005~0.1:1;Ammonium formate is 5~11:1 with the mol ratio of biacetyl monoxime;Ammonium formate adds the most in batches;After ammonium formate adds, the continuation return stirring time is 2~4h.
The preparation method of tetramethylpyazine the most according to claim 1, it is characterised in that: Extraction solvent is dichloromethane , chloroform , acetic acid second Ester.
CN201410630743.7A 2014-11-11 2014-11-11 Preparation method of tetramethyl-pyrazine Active CN104341359B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410630743.7A CN104341359B (en) 2014-11-11 2014-11-11 Preparation method of tetramethyl-pyrazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410630743.7A CN104341359B (en) 2014-11-11 2014-11-11 Preparation method of tetramethyl-pyrazine

Publications (2)

Publication Number Publication Date
CN104341359A CN104341359A (en) 2015-02-11
CN104341359B true CN104341359B (en) 2017-01-11

Family

ID=52497890

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410630743.7A Active CN104341359B (en) 2014-11-11 2014-11-11 Preparation method of tetramethyl-pyrazine

Country Status (1)

Country Link
CN (1) CN104341359B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110156701B (en) * 2019-06-25 2020-10-16 吴赣药业(苏州)有限公司 Synthesis method of 2,3,5, 6-tetramethylpyrazine
CN112666292A (en) * 2020-12-15 2021-04-16 四川省食品发酵工业研究设计院 Pretreatment method for determining tetramethylpyrazine in solid matrix and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1100765C (en) * 1998-11-11 2003-02-05 浙江大学 Process for preparing tetramethyl pyrazine
CN1173958C (en) * 2000-04-30 2004-11-03 广东药学院药物研究所 Compound capable of inhibiting thrombocyte agglutination and resisting thrombosis and its preparation and application

Also Published As

Publication number Publication date
CN104341359A (en) 2015-02-11

Similar Documents

Publication Publication Date Title
CN106046004A (en) Total synthesis method for theacrine
CN101891676A (en) Novel method for preparing 5-methyl-1-phenyl-2-(1H)-pyridone
CN104341359B (en) Preparation method of tetramethyl-pyrazine
CN111269131B (en) Process for preparing cyclopropyl ethyl amide by taking tri-n-propylamine as acid acceptor
CN109293574A (en) A kind of dehydroabietic acid aryl amine benzimidizole derivatives with anti-tumor activity and its preparation method and application
CN104844602B (en) A kind of preparation method of Li Gelieting
CN104356111B (en) A kind of method for preparing dabigatran etcxilate mesylate hydrolysis impurity
CN102367236A (en) Synthesizing technology of donepezil hydrochloride
CN103012268B (en) Novel preparation method for ivabradine
CN106397357B (en) A kind of preparation method of Trimetazidine Hydrochloride
CN107602399B (en) Preparation method of enkephalinase inhibitor intermediate
CN102241630A (en) Preparation method of dimethylmorphinan phosphate used as cough medicine
CN101967120A (en) Preparation method of 2-p-chlorobenzyl pyridine
CN106810554A (en) A kind of preparation method of Tadalafei compound
CN115433056B (en) Preparation method of biphenyl alcohol intermediate
CN102267983A (en) Sym-triazine derivative compounds containing sym-tetrazine rings and preparation method thereof
CN107935971A (en) It is a kind of(S)The preparation method of 3 hydroxyl tetrahydrofurans
CN110713471B (en) Synthetic method of trimetazidine hydrochloride
CN109053585B (en) Synthetic method of triclabendazole
CN103333103B (en) Method for preparing flupirtine maleate by one-pot method
CN109293587B (en) Preparation method of clofazimine and intermediate thereof
CN107043385A (en) A kind of method for preparing DRV intermediate
CN102381995A (en) Preparation method of metoprolol
CN101891677B (en) Preparation method of 6-methyl-2-ethyl-3-hydroxy pyridine
CN102558189B (en) Refining method of methyhaaltrexone bromide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 435229 Huangshi City, Hubei County of Yangxin Province Wang Fu Chi Town No. 18 Fenlu

Applicant after: Wuhan Wuyao Pharmaceutical Co., Ltd.

Address before: 430035 Hubei province in Qiaokou District of Wuhan city Gutian Road No. 5

Applicant before: Wuhan Wuyao Pharmaceutical Co., Ltd.

COR Change of bibliographic data
GR01 Patent grant
GR01 Patent grant